Skip to main content
BDSX
NASDAQ Life Sciences

Biodesix Sinks 29% After Q3 Revenue Miss, 2026 Guidance Cut to $101M-$103M

Tom Rudovsky · Reported by Benzinga
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$11.61
Mkt Cap
$209.334M
52W Low
$5.26
52W High
$31.97
52W Position info
121% above low
Off High info
64% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

BDSX has more than doubled off its 52-week low of $5.26.

Summary

Biodesix shares dropped 29.44% to $14 in after-hours trading after Q3 revenue of $24 million came in 12.4% below the $27.44 million analyst estimate. The company cut full-year 2026 revenue guidance to $101 million-$103 million from the prior $108 million-$114 million range, an 8.1% reduction at the midpoint. CEO Scott Hutton blamed fewer contributing sales reps than planned, heavier primary-care seasonality, and delayed Development Services projects, with some of that work now shifting into 2027. Diagnostic Testing revenue rose 16% to $23 million on 24% higher test volume, and gross margin held at 81%, but the top-line shortfall and softer outlook are what drove the selloff. The report follows the 8-K and 10-Q filed November 5th and comes days after Chief Commercial Officer Kieran O'Kane's November 2nd departure, adding to execution concerns.

At the time of this announcement, BDSX was trading at $11.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $209.3M. The 52-week trading range was $5.26 to $31.97. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Benzinga.


Price Chart

Share this article

Copied!

BDSX - Latest Insights

BDSX
Nov 05, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $16.00
Real-time Price: $9.00 info
Change: -$7.00 (-44%) info
Market Cap: $226.744M info
BDSX
Nov 05, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.70
Real-time Price: $9.00 info
Change: -$9.70 (-52%) info
Market Cap: $226.744M info
BDSX
Nov 05, 2026, 4:02 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $18.70
Real-time Price: $9.00 info
Change: -$9.70 (-52%) info
Market Cap: $226.744M info
BDSX
Aug 05, 2026, 4:24 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.78
Real-time Price: $9.00 info
Change: -$13.78 (-60%) info
Market Cap: $226.744M info
BDSX
May 29, 2026, 5:31 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $16.31
Real-time Price: $9.00 info
Change: -$7.31 (-45%) info
Market Cap: $226.744M info